September 14, 2022 — Details on late-breaking clinical trials to be presented during The VEINS (Venous Endovascular INte ...
Heart Failure
This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congestive heart failure (CHF). The channel includes news on HFpEF and HFrEF. Heart failure occurs when the heart is no longer able to pump as much blood as the body requires. This can lead to enlargement of the heart because the muscle works harder to supply blood, but the pumping is ineffective. This may be due to defects in the myocardium, such as an infarct, or due to structural issues such as severe valve regurgitation. The disease is divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or a left ventricular assist device (LVAD).
September 14, 2022
September 13, 2022 — ZOLL Medical Corporation, an Asahi Kasei company that manufactures medical devices and related ...
September 13, 2022
The Transcatheter Cardiovascular Therapeutics (TCT) conference, which is the Cardiovascular Research Foundation's (CRF) ...
September 12, 2022Sponsored Content
Blog | Artificial Intelligence
New research shows superiority of Ultromics’ AI in predicting cardiac-related death As the use of artificial ...
October 10, 2022
September 12, 2022 — Researchers at the National Institutes of Health have found that a novel blood test can be used to ...
September 12, 2022
September 9, 2022 — The probability of surviving sudden cardiac arrest outside hospital has more than doubled in 30 ...
September 09, 2022
September 9, 2 022 — A large-scale international study led by Mount Sinai has yielded the first risk score that can help ...
September 09, 2022
September 8, 2022 — A clinical trial led by investigators from Brigham and Women’s Hospital has found that the long-term ...
September 08, 2022
September 7, 2022 —  Nuwellis, Inc., a commercial-stage company focused on transforming the lives of people with fluid ...
September 07, 2022
Feature | Cardiovascular Business | By Melinda Taschetta-Millane
Here is a rundown of what you and your colleagues found to be most interesting in the fields of diagnostic and ...
September 07, 2022
September 6, 2022 — An analysis of more than 12,000 patients has found that the SGLT2 inhibitors dapagliflozin and empag ...
September 06, 2022
September 6, 2022 — Stopping statin treatment early could substantially reduce lifetime protection against heart disease ...
September 06, 2022
September 6, 2022 — Smokers have weaker hearts than non-smokers, according to research presented at ESC Congress 2022.1 ...
September 06, 2022
September 6, 2022 — Research presented at ESC Congress 2022 supports a causal relationship between air pollution and ...
September 06, 2022
September 2, 2022 — A restrictive oxygenation target in comatose patients resuscitated after out-of-hospital cardiac ...
September 02, 2022
September 2, 2022 — Dapagliflozin reduces the risk of cardiovascular death or worsening heart failure in heart failure ...
September 02, 2022